Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
…, KJ Andersen, MR Buras, MNP Vogt… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with Convalescent plasma: A systematic review and meta-analysis
…, CM van Buskirk, N van Helmond, MNP Vogt… - … : Innovations, Quality & …, 2023 - Elsevier
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
mortality and the differences between subgroups in hospitalized patients with COVID-19. …
YouTube as a source of medical information on the novel coronavirus 2019 disease (COVID-19) pandemic
Media coverage on coronavirus disease 2019 (COVID-19) has been extensive, yet large gaps
remain in our understanding of the role of social media platforms during worldwide health …
remain in our understanding of the role of social media platforms during worldwide health …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, KF Larson, JG Ripoll, KJ Andersen, MNP Vogt… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, JG Ripoll, KJ Andersen, ER Lesser, MNP Vogt… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
[HTML][HTML] Influence of intraoperative transesophageal echocardiography and pulmonary artery catheter monitoring on outcomes in liver transplantation
RE Hofer, MNP Vogt, T Taner, JY Findlay - Transplantation Direct, 2020 - journals.lww.com
Background. Anesthetic management of orthotopic liver transplantation (OLT) can be
challenging. Management involves responding to sudden hemodynamic shifts, addressing …
challenging. Management involves responding to sudden hemodynamic shifts, addressing …
[HTML][HTML] Post-operative functional neurological symptom disorder after anesthesia
RS D'Souza, MNP Vogt, EH Rho - Bosnian Journal of Basic …, 2020 - ncbi.nlm.nih.gov
A rare manifestation during the post-anesthetic period may include the occurrence of functional
neurological symptom disorder (FNSD). FNSD is described as neurological symptoms …
neurological symptom disorder (FNSD). FNSD is described as neurological symptoms …
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma
…, KF Larson, JG Ripoll, KJ Andersen, MNP Vogt… - medRxiv, 2021 - medrxiv.org
Background The United States (US) Expanded Access Program (EAP) to COVID-19
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …